APA (7th ed.) Citation

L, W., C, T., M, B., AE, B., X, R., & S, P. (2025). Development and evaluation of two whole-blood flow cytometry protocols for monitoring patients treated with JAK inhibitors. Immunotherapy advances, 5(1), ltaf006. https://doi.org/10.1093/immadv/ltaf006

Chicago Style (17th ed.) Citation

L, Waeckel, Talon C, Barrau M, Berger AE, Roblin X, and Paul S. "Development and Evaluation of Two Whole-blood Flow Cytometry Protocols for Monitoring Patients Treated with JAK Inhibitors." Immunotherapy Advances 5, no. 1 (2025): ltaf006. https://doi.org/10.1093/immadv/ltaf006.

MLA (9th ed.) Citation

L, Waeckel, et al. "Development and Evaluation of Two Whole-blood Flow Cytometry Protocols for Monitoring Patients Treated with JAK Inhibitors." Immunotherapy Advances, vol. 5, no. 1, 2025, p. ltaf006, https://doi.org/10.1093/immadv/ltaf006.